Turn Therapeutics (TTRX) Interest Expenses (2025 - 2026)

Turn Therapeutics' Interest Expenses history runs 3 years deep, the most recent figure standing at $2.0 million for Q1 2026.

• In Q1 2026, Interest Expenses rose 910.66% year-over-year to $2.0 million; the TTM figure through Mar 2026 stood at $2.0 million (changed N/A YoY), while the FY2025 annual figure was $8.1 million, up 108.3% from the prior year.
• Interest Expenses for Q1 2026 stood at $2.0 million, up from $747679.0 in the prior quarter.
• The five-year high for Interest Expenses was $5.7 million in Q3 2025, with the low at $147107.0 in Q4 2024.
• The 3-year median for Interest Expenses is $553484.5 (2024), against an average of $1.5 million.
• Peak annual rise in Interest Expenses reached 1477.39% in 2025, while the deepest fall reached 408.26% in 2025.
• Turn Therapeutics' Interest Expenses stood at $147107.0 in 2024, then jumped by 408.26% to $747679.0 in 2025, then soared by 160.81% to $2.0 million in 2026.
• Business Quant data shows TTRX's Interest Expenses at $2.0 million in Q1 2026, $747679.0 in Q4 2025, and $5.7 million in Q3 2025.